Prevent Risks by Early interVEntion at Nighttime in Type 1 diabetes for Kidney Disease (PREVENTKD)

The purpose of this study is to determine if the early treatment with a blood pressure medication can prevent or delay the development of kidney disease in people with Type 1 diabetes and normal blood pressure.  Only a fraction of persons with Type 1 diabetes (less than 40%) develop diabetic kidney disease.  This study is aimed at demonstrating that it is possible to prevent kidney disease in its early stages in patients who have type 1 diabetes by taking a blood pressure medication before bedtime. Patients will be compensated for their time and travel expenses.

You may be eligible to participate in this study if you:

• Have been diagnosed with Type 1 diabetes for at least 5 years
• Have no history of high blood pressure and are not taking any blood pressure medications
• Have no history of kidney disease
• Are not pregnant or breast-feeding

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.